At a glance
What it is
Bladder dysfunction resulting from disruption of the neurological control of urination — involving the brain, spinal cord, or peripheral pelvic nerves. The bladder may be hyperreflexic (overactive, failing to store), hypotonic (underactive, failing to empty), or show detrusor-sphincter dyssynergia. The pattern depends on where the nervous system is affected. Can cause kidney damage if high bladder pressures are not managed.
Symptoms
Overactive type: urinary urgency, frequency, urge incontinence. Underactive type: difficulty initiating urination, incomplete emptying, overflow incontinence. Both types: recurrent urinary tract infections (often the presenting sign), bladder stones. High-pressure dysfunction causes upper urinary tract damage. Severity and quality-of-life impact vary widely depending on the underlying neurological condition.
Approach
Treat the underlying neurological disease. Bladder-specific management: intermittent clean catheterisation for retention; anticholinergics or beta-3 agonists for overactivity; Botox injected into the detrusor for refractory overactivity or dyssynergia; sacral neuromodulation and spinal cord stimulation for selected cases; intrathecal baclofen for spasticity-related dysfunction. Physiotherapy for pelvic floor and bladder retraining.
What neurogenic bladder is
The normal bladder stores urine at low pressure and empties completely on a voluntary cue. This requires coordinated activity between the detrusor muscle (bladder wall), the urethral sphincter, and an intact neural control system spanning the pontine micturition centre, sacral spinal cord (S2–S4), sympathetic pathways (T10–L2), and the pudendal nerve. Disruption at any point in this system produces neurogenic bladder.
**Types of neurogenic bladder**
*Uninhibited (supraspinal):* Brain lesions — stroke, Parkinson's disease, dementia, brain tumours — impair the brain's inhibitory influence on the spinal micturition reflex. The result is bladder overactivity with urgency, frequency, and urge incontinence. Bladder pressures remain low and kidney damage is uncommon.
*Spastic (upper motor neuron):* Spinal cord damage above T10 (traumatic or atraumatic) disconnects the bladder from pontine coordination. The detrusor becomes hyperreflexic. Critically, detrusor-external sphincter dyssynergia (DESD) develops — the detrusor contracts against a simultaneously contracting sphincter. This causes urinary retention, high intravesical pressures, vesicoureteral reflux, and — if untreated — progressive kidney damage.
*Flaccid (lower motor neuron):* Sacral spinal cord or peripheral pelvic nerve injury (S2–S4 damage from cauda equina injury, pelvic surgery, diabetes mellitus, or lumbar disc disease) causes loss of detrusor contractility. The bladder becomes large, hypotonic, and fails to empty. Overflow incontinence is common; catheterisation is needed.
*Mixed:* Multiple levels of nervous system involvement (common in multiple sclerosis) produce mixed patterns that may combine elements of overactivity and underactivity.
**Causes**
Neurogenic bladder can result from any condition affecting the neural control of the lower urinary tract, including: - Spinal cord injury (most common cause of spastic neurogenic bladder) - Multiple sclerosis - Stroke and brain injury - Spina bifida and tethered cord syndrome - Parkinson's disease and other neurodegenerative diseases - Peripheral neuropathy (diabetic, post-surgical, post-irradiation) - Cauda equina syndrome
**Diagnosis**
Urodynamic studies (cystometry, pressure-flow studies, sphincter EMG) precisely characterise the type of dysfunction and guide treatment decisions. Imaging (ultrasound, cystography) assesses the upper urinary tract for damage. Video urodynamics are used in complex cases.
**Management principles**
The primary goals are to protect the upper urinary tract from high-pressure damage, prevent recurrent infections, and restore as much bladder function and continence as possible.
- *Clean intermittent self-catheterisation (CISC):* the cornerstone of management for underactive bladder and the most effective strategy for preventing upper tract damage in DESD - *Anticholinergic medications:* reduce detrusor overactivity; side effects limit long-term use - *Botulinum toxin A (Botox) injection:* cystoscopic injection into the detrusor dramatically reduces overactivity, incontinence, and bladder pressures with effects lasting 6–12 months - *Sacral neuromodulation:* implanted electrical stimulator modulates the sacral nerve roots — effective for urgency incontinence and non-obstructive retention - *Intrathecal baclofen pump:* directly suppresses spinal cord excitability, reducing both limb spasticity and detrusor hyperreflexia in high spinal cord injury and MS - *Spinal cord stimulation:* can improve bladder function and reduce autonomic dysreflexia risk in selected spinal cord injury patients
Treatment options at Alimran Medical Center
Neuromodulation
Injection therapies
- Botox® injections
- Ozone injection
- Trigger point injections
Advanced therapies
Physiotherapy
- Electrical stimulation
- Short and long wave therapy
- Laser therapy
- Ultrasound therapy
- Pelvic floor rehabilitation and bladder retraining
Book a consultation
The secretary schedules first appointments during clinic hours; please have prior imaging, operative notes and a current medication list available at the time of the call.
This page provides general information about neurogenic bladder and is not a substitute for individual medical assessment. If your symptoms are severe or worsening, contact a clinician promptly.